Xspray Pharma: HyNap-Dasa 505(b)(2) has reached BE
Redeye leaves a comment on Xspray following the announcement that its HyNap-Dasa 505(b)(2) reached bioequivalence compared to its reference drug Sprycel. We raise our Base Case.
FE
Filip Einarsson
Disclosures and disclaimers